COAST-TO-COAST
Strategic experts in oncology drug development, regulatory, and operational services
OUR
STORY
Our academically trained physician-scientist consultants are seasoned Biotech and Pharmaceutical C-suite executives with decades of drug development experience in oncology and immunology, spanning preclinical to marketed drug development. We combine clinical backgrounds in oncology, bone marrow transplantation, immunology, and clinical diagnostics with complete value-chain expertise in drug development.
OUR
GOALS
Coast-to-Coast BioConsultants offers specialized consulting services aimed at facilitating the success of biotech and pharmaceutical companies in bringing essential oncology, hematology, or immunology therapies to market. Our team helps in developing innovative strategies and achieving growth in the industry. Read on to explore how we can help your business thrive.
OUR SERVICES
Coast-to-Coast BioConsultants specializes in helping oncology-focused biotech and pharmaceutical companies solve challenges and develop strategies for clinical and drug development success. With geographic coverage of East-West US Coasts as well as Europe and Asia-Pacific, our objective is to facilitate the success of our clients in this vital industry. Available as a team, individually, or a hybrid, we customize solutions to meet each client's needs. Our dedicated consultants can help you achieve your goals as you navigate the complexities of the biotech and pharmaceutical landscape.
STRATEGIC AND OPERATIONAL SERVICES
Expertise in:
-
Preclinical Development, Data Interpretation, and Study Design
-
Translational and Biomarker/Companion Diagnostic Development
-
Medical Affairs and Thought-Leader Engagement and Networking
-
Strategic Input and Oversight of CMC and Clinical Operations/CRO Study Execution
-
Seats or Advisory Roles for Scientific Committees and Company Boards
-
Mentorship & Coaching for Leadership & C-suite Teams
DUE DILIGENCE REVIEWS AND DEAL PARTICIPATION
Offering Assistance In:
-
Regulatory Advice and Engagement across EMA, FDA, PMDA, NMPA, MHRA, and TGA
-
Review of Regulatory Submissions and Communications
-
Safety and Pharmacovigilance Review and Management
-
Data Strengths and Deficiencies
CLINICAL AND DRUG DEVELOPMENT
Expertise across:
-
Hematological and Solid Tumor Malignancies
-
Benign Hematology
-
Immunodeficiencies & Immune Dysregulation Syndromes
-
Clinical Development Phases 1 through 4
